Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Once we forward split, I’ll think about it.
Exactly. I too believe he is trying to get more tutes invested to help raise the price and resist a hostile situation.
Unfortunately, he can’t build more interest without more data being released.
If he could somehow get that $150M offering secured by some big name……..
Which begs the question…..How much of us here will have sold too early to really realize the full potential of Anavex the BP.
Right….
I’ll liquidate my holdings right away.
Nonsense
“I’ll take no further interest or concerns with PRE-084. In regard to the Anavex drugs and the treatment of CNS diseases, it’s irrelevant.”
Exactly.
Why even try and go down that rabbit hole when it ends up pointless. It is not an Anavex drug so trying to understand why this or why that only distracts from the truly impossible.
Anavex may be on the cusp of treating horrible diseases with a pill.
If we can find ways to identify the condition before it's evident, if we could take a piece of hair and find it, then we could treat it prophylactically and then maybe you don't get it," the 60-year-old actor explained.
Hmmm…. Where have I heard prophylactically from before….
Good for MJF. I hope he achieves his goal of finding a cure.
https://bestlifeonline.com/michael-j-fox-parkinsons-symptoms-news/
And so begins the cycle of FUD.
Glad to read your perspective Falconer.
I don’t know Tred. To date, who has more real outcomes/stories of benefit?
A p2 with, what was it 32 patients, or the hundreds upon hundreds that took the “approved” therapy.
We shall see when the curtain opens.
That makes no sense. AD isn’t even figured in the pps right now, so how can it be overvalued?
Right now it seems like Rett alone as has been stated.
Parkinson’s isn’t even figured either.
What P2 positive top line a few months ago.
AVXL is clearly undervalued no matter how the spin attempts are
Not meaningless.
At least we know you’ll be around longer.
Wow, on it. 5 minutes ago only.
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease
That is correct with Anavex trying to prove it in humans.
You would also be correct that Amyloid was beneficial in mice, and BP is STILL trying to prove that in humans 30 years later.
What’s there to analyze?
That’s what the previous trial was for.
This one should just be a confirmation.
No?
Personally. I’d wait till we reach Monopolyland. Where every quarter, we pass go.
Iceberg comes to mind.
This giant mass of possibilities.
Reading to sink the unsinkable
Hmmmm…. And that actually wasn’t her in the picture walking down the road……..
Changed their name after a failed trial. Few years ago they were supposedly “it”, same position SAVA is in now
“I’m hoping working with Anavex can prove to be beneficial for Batten disease patients. Maybe we could also use this as kind of a model project that we can apply to other rare diseases as well,” Francis said.
Certainly possible…..
https://battendiseasenews.com/2021/03/05/scientist-wins-grant-to-study-cln6-batten-advance-early-trials/
What one calls doubling down, others may call waking up to reality.
They understand time is NOT on their side to get their “crap” approved before a new generation of possible stabilizing/improving therapies DO get approved and render their 10-20-30 years “research” useless.
Seems to be a lot of Sigmar1 research papers floating around lately…….making one beg the question:
WHAT IF!
After watching that, I can see why Missling did what he did with Biogen when MS was still on the trial roadmap.
He was thinking he could collaborate with a BP and all he got was a cold shoulder because Biogen knew what they were up against.
One day……Dr. Christopher Missling TIME magazine man of the year.
Sounds like an easy job for Amazon pharmacy
Don’t forget about the effect it could have with a hostile takeover.
If he could get an ultra rare and/or Rett to market before the bigger trial readout, one would think investors/tutes would open their eyes and understand the possibilities.
Which was probably misdiagnosed. = )
Can’t believe I’m agreeing with your thoughts on this one. What’s interim look when you have Rett and PD readouts that should give many investors the idea of how the MOA works many months before the main event.
I watch that other stock and how it drops to low 40s then up it goes. Makes me think of doing quick flips, but knowing my luck…. as soon as I have a position, down it goes.
Why would that post even be removed as a sticky is beyond me
PD was never before seen improvement(absolutely great news), yet here we are as if THAT never happened.
SAVA smokescreen is done and data readout through the next 18 months will put Anavex in their rightful place either way it reads.
I’d think news in the next 2 weeks.
Isn’t that what happened last investors conference?
The Flippening between SAVA and AVXL
It’s just the CEO of a promising biotech telling a story since no one wants to print it….YET.
Imagine the response if Missling calmly got to the mic, held up a pill of Blarcamesine and said;
What if I were to tell you, this little pill(holding up for camera to see), could potentially change MILLIONS of lives…..for the better!
One day soon…….hopefully
Wonder how each of the other trial positive/negative results affect that 60% for Alzheimer’s?
I do agree that when it’s time for “the” move, this is what will occur. Everyone expecting a pullback but it never occurs, until way later.
Then again, I thought that moment was upon us a few times already.
In that case, programmers did a number on the crypto market a few days ago.
Feels like we are being cradled and being rocked back and forth to sleep.
Can’t we wake up and it’s Dec 2022 already.
Woke up, looked for news, saw none, sold trading shares, bought back for a gain of 25 shares in the 401k.
Wish I started a long time ago.
There WAS that one article discussing the chart of “it” and the author said it looked like teens was the target.
Think it was on SA
Blotting the blot chart, what a great idea.
Good call on the SAVA rug last week. I know you were mentioning it over and over but there were those here that were debating against that happening.
Have to admit it though. That CEO may/may not go to jail, but I bet he made out like a bandit
The LONG game
2 more years can’t come soon enough